Total plasma homocysteine (tHcy) was measured by high pressure liquid chromatography (HPLC) method in 28 patients (12 females and 16 males) at the onset of type 1 diabetes mellitus (T1DM), 4 females during diabetes ketoacidosis (DKA) and 154 (68 females and 86 males) during follow-up. Serum folate, pyridoxal 5' phosphate (PLP) and Vitamin B12 (Vit B12) were also measured. Plasma tHcy levels were not found significantly different in T1DM patients known to have diabetes (males 9.2
Introduction
Homocysteine (Hcy) is an intermediate sulphur-containing amino acid formed during methionine metabolism. Many factors may determine an alteration of the Hcy metabolism, such as low levels of folate, Vitamin B6 (Vit B6) and Vitamin B12 (Vit B12). A strong correlation between plasma Hcy levels and cigarette smoke, large consumption of coffee, obesity, hypertension, diabetes, age and gender has been found (1) . Moreover increased plasma Hcy levels seem to be implicated in the atherosclerosis process (2, 3) . A link between plasma hyperHcy and micro and macro-vascular lesions in adult patients with T1DM (4, 5) and in adolescent with type 1 diabetes has been recently reported (6) . The link with adolescent type 1 diabetes mellitus (T1DM) is not universally accepted, since difference in dietary intake of folates and Vit B12 (reflected by higher plasma levels) might be a confounding factor (7) . It remains to be clarified if hyper-Hcy might be considered a predictor of future micro-macrovascular complications in T1DM or it simply rises, when chronic microvascular or macrovascular complications are already established. One could speculate that if hyper-Hcy is a marker responsible in part, of such chronic complications such as diabetic nephropathy, it should be possible to find plasma hyper-Hcy in a consistent number of uncomplicated T1DM patients, since about 20% of them develop nephropathy during their life. Since patients with higher albu-min excretion rate (AER) show a higher frequency of late kidney complications than those subjects with AER < 20 mg 24 hours, we think that higher plasma tHcy levels should be found in those subjects with AER > 20 mg 24 hours (8) .
The aim of this study is therefore to investigate, in a large sample of Sardinian without complications T1DM patients over a large range of age, the possibility that in a cluster of them plasma hyper-Hcy could be a predictor of macro and micro vascular complications.
Patients and Methods
A total of 186 patients with T1DM, 84 females and 102 males, with age ranging from 2 to 27 years (median 13 years), with age at onset ≤ 15 years and without clinical signs of chronic microvascular or macrovascular complications were studied. Twenty-eight were observed at the onset of the disease, 154 were studied during a normal follow-up (diabetes duration ranging from 1 to 21 years), four patients were studied during a diabetes ketoacidosis (DKA) (diabetes duration ranging from 2 to 11 years), but due to the DKA they were not included in the cumulative analysis. All patients were treated with insulin (at least three injections a day). In all patients, hemoglobin A1c (HbA1c), uric acid, serum creatinine, triglycerides, total cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL) cholesterol were determined by standard methods. Urine was collected over 24 hours for AER in three different occasions over a period of 6 months. Total plasma homocysteine (tHcy) levels were measured with a high pressure liquid chromatography (HPLC) system and fluorescence detection (λex = 385 nm, λem = 515 nm) (9) at the Department of Clinical Chemistry, Catholic University, Rome, Italy; Serum folate, pyridoxal 5'-phosphate (PLP) and Vit B12 were also determined in all patients with standard methods in the same Department. One hundred healthy control Sardinian subjects (51 females and 49 males), aged 3 to 29 years (median 12.2), were also studied. Blood samples were collected in the morning after 12 hours of fasting. Mean and standard deviation were calculated for each studied parameter and the differences were evaluated with the Student T test. The correlation indexes and the relative value of r were calculated with SPSS-10 program. p < 0.05 was considered to be statistically significant.
Results
Clinical and laboratory findings of the T1DM patients are summarized in Table 1 : patients were divided in males and females, if they were studied at the onset of diabetes (newly diagnosed) or during the follow-up (known diabetes). Serum creatinine was below 100 µmol/l in all patients and HbA1c was higher in newly diagnosed patients In T1DM considered as a whole (n = 186), plasma tHcy values (8.15 ± 5.99 µmol/l) were not statistically significantly different from the controls. In the healthy control subjects, mean plasma tHcy levels were 8.5 ± 3.2 µmol/l and no significant difference was found between females and males (7.8 ± 2.55 and 8.7 ± 3.5 µmol/l respectively). The distribution curves of plasma tHcy values in the control subjects and in the T1DM patients were comparable ( Fig. 1) and only 6 T1DM patients showed plasma tHcy values higher than the maximum values found in controls. Plasma tHcy levels were lower in females than in males, but this difference was significant only in 154 T1DM studied at follow up (7.0 ± 2.8 in females versus 9.17 ± 7.7 in males, p = 0.0281). This difference was not significant comparing the newly diagnosed and the known diabetes for sex. In the four patients studied during DKA, tHcy was 3-times lower (2.76 ± 1.33 µmol/l) than in healthy control and in diabetic patients. In T1DM in a whole (n. 186), a significant correlation between plasma tHcy and age, diabetes duration and serum uric acid was found (Table 2 ). In the healthy control plasma tHcy correlated with age, but at a lower level of significance (p ≥ 0.01). When a multiple linear correlation was performed in T1DM patients only age correlated significantly as an independent variable to tHcy (p = 0.001) (Fig. 2) , while diabetes duration and serum uric acid, both highly correlated with age, were not fundamental independent variables for tHcy. No significant correlation was found between plasma tHcy values and HbA1c, lipid parameters, and microalbuminuria (r = 0.08). AER was limited in our known diabetes patients and it was medially 2.5 ± 4.2 mg/24 hours, below the values of 20 mg/24 hours, which was considered to be discriminator for nephropathy. It was undetectable in newly diagnosed patients, with exception of one male patient (10 mg/24 hours). Also when we divided the patients in two groups with AER < 5 mg/ 24 hours and > 5 mg/24 hours, plasma tHcy was not significantly different (median and range 7.9 (1.6-28.4) and 6.3 (1.9-48.3) respectively). In the six T1DM patients (see Fig. 1 ), who showed plasma tHcy levels above the maximum level found in healthy controls (20 µmol/l), only diabetes duration (9.5 years, range 2-15 years) was significantly different from the other T1DM patients (p = 0.041), besides, of course, plasma tHcy (31 ± 11. 7 µmol/ l), while AER was not significantly different (2.9 ± 3.3 mg/ 24 hours). Serum folate, PLP and Vit B12 were in the normal range (12.6 ± 3.6 ng/ml, 20.1 ±10.8 ng/ml and 416.7 ± 41.9 pg/ml respectively) in all T1DM patients and no correlation between plasma tHcy values and these three parameters was found. Females vs Males * p = 0.029, Newly diagnosed vs known diabetes, ** p < 0.001 *** Only in one newly diagnosed patient microalbuminuria was 10 mg/24 hours. 
Discussion
Typical microvascular complications of diabetes are retinopathy, nephropathy and neuropathy, which seem to be related to increase in glucose flux through polyol pathway. The altered polyol metabolism is responsible of increased protein glycation, depletion of myoinositol and reduction of the ATP-dependent proton-potassium pump Na + ,K(+)-ATPase (10) . Moreover the increased production of transforming growth factor beta(1) (TGF-β1) can cause vascular alterations (such as increased blood flow and increased vascular permeability, abnormal viscosity, dysfunctions of platelets and endothelial cells and changes in oxidative stress), which might interact with a genetic predisposition, thus leading to these typical complications of diabetes (11) . These alterations finally determine endothelial tissue damage and consequent occlusive angiopathy (12) . The exact role of each one of these components is not perfectly known, but an adequate insulin therapy is usually able to normalize glucose level and to slow down the progression of vascular damage, in most but not in all of the patients.
Plasma hyper-Hcy level has been considered an important parameter connected to endothelial lesions in adult diabetics. In fact diabetic patients with poor metabolic control, early age onset and folate deficiency show elevated plasma Hcy levels (13) . A synergistic action between Hcy and AGE (Advanced Glycation End Products) seems to increase the release of soluble thrombomodulin (sTM), a marker of endothelial cells damage, in "in vitro" experiments in cells of human umbilical vein (14) . This suggests that tHcy could represent the conjunction between the metabolic alteration of diabetes and the endothelial vascular damage.
In adult diabetic patients, a direct relation between micro and macro-albuminuria (15, 16) , glomerular filtration rate (17) , diabetic nephropathy (4), cardiovascular disease (5) and plasma Hcy levels has been reported. The same can not be supported by other studies (18, 19) , in T1DM patients, where the levels of plasma tHcy were found in the normal range for controls mached for age and sex. Other authors found a marked increase of plasma tHcy concentration using methionine loading test in young diabetic patients with > 70 µg/min of microalbuminuria (fasting values: 14.7 ± 5.6 µmol/l; after methionine load: 34.2 ± 12.6 µmol/l) and in patients with proliferative retinopathy (fasting values 15.1 ± 5.0 µmol/ l; after methionine load 36.8 ± 12.5 µmol/l), which suggest an unbalanced methionine metabolism when the diabetes dates of long time (5) . Thus an increased plasma tHcy level might contribute to an increased morbidity from cardiovascular disease in adolescent and young adults with diabetic retinopathy and nephropathy. Recently Jager et al 2001 (20) reported that the increase of plasma tHcy precedes the appearance of microalbuminuria. In fact an increase of 5 µmol/l over the normal value for age was associated with an increased risk of developing microalbuminuria. One of the aims of our study was to detect possible differences in plasma tHcy levels relative to the AER, in order to evaluate the possibility that plasma tHcy values might represent a marker of possible evolution to diabetic nephropathy. We were not able to find any correlation between tHcy and urinary albumin excretion. Also the 6 patients with the highest tHcy levels ( > 20) did not show higher urinary albumin excretion rate than the other patients, although diabetes duration was significantly longer. In summary, our young T1DM patients do not show abnormal values of tHcy within an AER values ≤ 10 mg/24 hours. This may be due in part to an accurate insulin therapy and a free diet with regular folate intake. The only significant difference was found for the sex, with tHcy values being lower in females than in males, as previously reported (21) . Other studies (22) show evidence that in patients with severe retinopathy, the most elevated levels of plasma tHyc are confined in those with serum creatinine level > 100 µmol/l.
The low level of plasma tHcy in the four patients with DKA is not usual in T1DM. Due to the low number of subjects, this phenomenon is difficult to evaluate, but it may be considered a consequence of severe derangement of glucose, lipid and electrolytes homeostasis, which may be rapidly corrected by insulin and glucose treatment.
In conclusion our results confirm recent data, which report normal level of plasma Hcy in T1DM patients (23) . In any case, considering that a trend to higher values of plasma tHcy with the age (r 2 = 0.17, p < 0.001) is more significant in young T1DM than in our control group of the same age, we suggest in such a metabolic situation, the measure of plasma tHcy levels in order to prevent the endothelial damage.
In particular patients with atypical anaemia, as well as in an undernutrition state and with an initial increase of serum creatinine levels ( > 100 umol/l) plasma tHcy should be monitored, since serum folate concentration must be maintained elevated by adding folate to the diet, while the intake of proteins especially a high content of methionine must be reduced.
